The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity
PublisherBioMed Central Ltd.
MetadataShow full item record
AbstractBackground: The outcome of a viral infection is regulated by complex interactions of viral and host factors. SARS coronavirus (SARS-CoV) engages and regulates several innate immune response pathways during infection. We have previously shown that the SARS-CoV Papain-like Protease (PLpro) inhibits type I interferon (IFN) by inhibiting IRF3 phosphorylation thereby blocking downstream Interferon induction. This finding prompted us to identify other potential mechanisms of inhibition of PLpro on IFN induction. Methods: We have used plasmids expressing PLpro and IRF3 including an IRF3 mutant that is constitutively active, called IRF3(5D). In these experiments we utilize transfections, chromatin immunoprecipitation, Electro-mobility Shift Assays (EMSA) and protein localization to identify where IRF3 and IRF3(5D) are inhibited by PLpro. Results: Here we show that PLpro also inhibits IRF3 activation at a step after phosphorylation and that this inhibition is dependent on the de-ubiquitination (DUB) activity of PLpro. We found that PLpro is able to block the type I IFN induction of a constitutively active IRF3, but does not inhibit IRF3 dimerization, nuclear localization or DNA binding. However, inhibition of PLpro's DUB activity by mutagenesis blocked the IRF3 inhibition activity of PLpro, suggesting a role for IRF3 ubiquitination in induction of a type I IFN innate immune response. Conclusion: These results demonstrate an additional mechanism that PLpro is able to inhibit IRF3 signaling. These data suggest novel innate immune antagonism activities of PLpro that may contribute to SARS-CoV pathogenesis. Copyright 2014 Matthews et al.
SponsorsNational Institutes of Health, NIH: K22AI077797
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84938521107&doi=10.1186%2fs12985-014-0209-9&partnerID=40&md5=f07c2e5f89d8a155d9c62e2160aab0fe; http://hdl.handle.net/10713/12411
- SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex.
- Authors: Chen X, Yang X, Zheng Y, Yang Y, Xing Y, Chen Z
- Issue date: 2014 May
- Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
- Authors: Ratia K, Kilianski A, Baez-Santos YM, Baker SC, Mesecar A
- Issue date: 2014 May
- Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
- Authors: Yang X, Chen X, Bian G, Tu J, Xing Y, Wang Y, Chen Z
- Issue date: 2014 Mar
- Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling.
- Authors: Frieman M, Ratia K, Johnston RE, Mesecar AD, Baric RS
- Issue date: 2009 Jul
- Severe acute respiratory syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated signalling pathways.
- Authors: Li SW, Lai CC, Ping JF, Tsai FJ, Wan L, Lin YJ, Kung SH, Lin CW
- Issue date: 2011 May